IHBI Advances is the quarterly newsletter from the QUT Institute of Health and Biomedical Innovation (IHBI). Each issue highlights research outcomes and profiles researchers as they seek better health in our lifetime through multidisciplinary research innovation.
April 2019 Edition 37
In this issue:
13-06-2019 Gut health is increasingly being recognised as important in improving digestion, boosting the immune system, physical health and even brain and mental health. IHBI researchers are investigating the link between gut health and the management of depression.
13-06-2019 Chronic progressive arthritis is a symptom in a significant number of people with haemochromatosis, also called iron overload disorder. But new IHBI research is throwing into doubt the long-held belief that too much iron is the direct cause of arthritis among people with haemochromatosis.
13-06-2019 Research suggests that between 5 and 20 per cent of ex-service personnel will develop post-traumatic stress disorder (PTSD) at some point in their lives. IHBI researchers aim to better understand the factors influencing veteran health and physical symptoms associated with PTSD.
13-06-2019 In Australia, 17 729 men are estimated to have been diagnosed with prostate cancer in 2018, with a loss of 3500 lives. The majority of prostate cancer tumours are not life-threatening but present diagnostic processes are unable to accurately predict which men require treatment.
13-06-2019 Globally, vaccination is estimated to save between 2 and 3 million lives annually. Yet low immunisation rates are a significant public health concern. IHBI researchers are part of a solution involving pharmacists that started in Queensland and has spread across Australia.
13-06-2019 Hip and femur fracture treatments require expert surgical skills and an implant shape that closely matches the patient’s anatomy when inserted into the canal of the thigh bone, called the femur.
- Phone: 3138 6073